Tom Schoenherr

Tom Schoenherr is responsible for the strategic, financial and operational leadership of the organization.

Tom joined Ambry in 2017 as Chief Commercial Officer and was responsible for the execution of Ambry’s go-to-market strategy and overseeing all commercial functions including service, support, sales, marketing, business development, managed care and genetic specialists. Prior to Ambry, Tom spent more than 20 years in leadership positions in the molecular diagnostics space, most recently as the CCO of Omada Health where he was responsible for driving business growth and increasing market share. He also served in similar roles at Counsyl, Quest Diagnostics, Siemens Healthcare and Abbott Diagnostics. Tom earned his BS from Michigan State University and completed his Executive Business Development Program from the University of Notre Dame.